骨髓细胞特异性β2-上腺素受体表达的丧失改善了急性缺血后的心脏功能和重塑

相关实验视频

Updated: Jul 8, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.6K

Tapas K Nayak, Anamika Bajpai, Viren Patwa

    bioRxiv : the preprint server for biology
    |December 11, 2023
    PubMed
    概括

    骨髓状细胞对β-2上腺素受体 (β2AR) 的特异性缺失增强了血细胞增生,改善了心脏功能,并减少了心肌梗塞后的纤维化. 这突显了β2AR在调节心脏损伤后免疫细胞修复中的新作用.

    更多相关视频

    Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

    Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

    Published on: August 17, 2022

    2.6K
    Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

    Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

    Published on: April 17, 2021

    8.5K

    相关概念视频

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    436